These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11206190)

  • 1. Gastrointestinal transit of dosage forms in the pig.
    Davis SS; Illum L; Hinchcliffe M
    J Pharm Pharmacol; 2001 Jan; 53(1):33-9. PubMed ID: 11206190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers.
    Podczeck F; Course N; Newton JM; Short MB
    J Pharm Pharmacol; 2007 Jul; 59(7):941-5. PubMed ID: 17637188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects.
    Coupe AJ; Davis SS; Wilding IR
    Pharm Res; 1991 Mar; 8(3):360-4. PubMed ID: 2052525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gastric emptying of food as measured by gamma-scintigraphy and electrical impedance tomography (EIT) and its influence on the gastric emptying of tablets of different dimensions.
    Podczeck F; Mitchell CL; Newton JM; Evans D; Short MB
    J Pharm Pharmacol; 2007 Nov; 59(11):1527-36. PubMed ID: 17976264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meal-induced acceleration of tablet transit through the human small intestine.
    Fadda HM; McConnell EL; Short MD; Basit AW
    Pharm Res; 2009 Feb; 26(2):356-60. PubMed ID: 18982248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of small intestinal transit and colon arrival times of non-disintegrating tablets administered in the fasted state.
    Pišlar M; Brelih H; Mrhar A; Bogataj M
    Eur J Pharm Sci; 2015 Jul; 75():131-41. PubMed ID: 25769525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transit of pharmaceutical dosage forms through the small intestine.
    Davis SS; Hardy JG; Fara JW
    Gut; 1986 Aug; 27(8):886-92. PubMed ID: 3732895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Diurnal Variation and Food on Gastrointestinal Transit of
    Kambayashi A; Sako K; Kondo H
    J Pharm Sci; 2020 Feb; 109(2):1020-1025. PubMed ID: 31600549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transit of dosage forms through the small intestine.
    Yuen KH
    Int J Pharm; 2010 Aug; 395(1-2):9-16. PubMed ID: 20478371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive radionuclide esophagogastrointestinal transit study: methodology, reference values, and initial clinical experience.
    Antoniou AJ; Raja S; El-Khouli R; Mena E; Lodge MA; Wahl RL; Clarke JO; Pasricha P; Ziessman HA
    J Nucl Med; 2015 May; 56(5):721-7. PubMed ID: 25766893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of colonic transit of nondisintegrating tablets in healthy subjects.
    Price JM; Davis SS; Wilding IR
    Dig Dis Sci; 1993 Jun; 38(6):1015-21. PubMed ID: 8389686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of density on the gastrointestinal transit of pellets.
    Devereux JE; Newton JM; Short MB
    J Pharm Pharmacol; 1990 Jul; 42(7):500-1. PubMed ID: 1980292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Quantitative Review and Meta-models of the Variability and Factors Affecting Oral Drug Absorption-Part II: Gastrointestinal Transit Time.
    Abuhelwa AY; Foster DJR; Upton RN
    AAPS J; 2016 Sep; 18(5):1322-1333. PubMed ID: 27439620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of absorption kinetics of orally administered theophylline in rats based on gastrointestinal transit monitoring by gamma scintigraphy.
    Haruta S; Kawai K; Jinnouchi S; Ogawara KI; Higaki K; Tamura S; Arimori K; Kimura T
    J Pharm Sci; 2001 Apr; 90(4):464-73. PubMed ID: 11170036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations.
    Christensen FN; Davis SS; Hardy JG; Taylor MJ; Whalley DR; Wilson CG
    J Pharm Pharmacol; 1985 Feb; 37(2):91-5. PubMed ID: 2858556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suitability of the cynomolgus monkey as an animal model for drug absorption studies of oral dosage forms from the viewpoint of gastrointestinal physiology.
    Ikegami K; Tagawa K; Narisawa S; Osawa T
    Biol Pharm Bull; 2003 Oct; 26(10):1442-7. PubMed ID: 14519952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoscintigraphy confirms consistent tamsulosin release from a novel triple-layered tablet.
    Hodges LA; Sime KA; Creech LA; Connolly SM; Barclay ST; Kwon MC; Jeon BJ; Shim SM; Wang HS; Stevens HN; Park JS
    Int J Pharm; 2013 Sep; 454(1):41-6. PubMed ID: 23834829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative evaluation of the gastric transit of floating and non-floating matrix dosage forms].
    Timmermans J
    Bull Mem Acad R Med Belg; 1990; 145(8-9):365-75. PubMed ID: 2099235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects.
    Perkins AC; Blackshaw PE; Hay PD; Lawes SC; Atherton CT; Dansereau RJ; Wagner LK; Schnell DJ; Spiller RC
    Clin Ther; 2008 May; 30(5):834-44. PubMed ID: 18555931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.